Fermer le menu

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results. Avadel currently markets products in the hospital and primary care spaces. The Company is headquartered in Dublin, Ireland with operations in St. Louis, Missouri and Lyon, France.


Strategic application domain: Human Medicine

Application market: Neurology & Mental Health Disorders, Others

Type of activity: Therapeutics, Pharma or Biotech

Technologies: Others

Created on jan. 1st, 1990 - 150 employees



Parc Club moulin à Vent, 33 av. du Dr. Georges Levy 69693 Venissieux



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.